On March 15, 2017, WABC Birmingham, Alabama interviewed AFAR Scientific Director Steven Austad, PhD, in a segment exploring the drug, Rapamycin, and its impact on longevity and age-related diseases.
In the interview, Dr. Austad discusses his work previously using Rapamycin in mice, and the promising outlook for the drug in upcoming human trials. Dr. Austad describes Rapamycin’s effect in mice as “almost a miracle drug”. He believes this medication has the ability to slow the progression of age-related diseases and extend longevity. Watch full video here.
Steven Austad, PhD is a Distinguished Professor and Department Chair in the Department of Biology at the University of Alabama, Birmingham.
For more information on longevity, see AFAR’s Longevity InfoAging guide here.
